Literature DB >> 12796534

Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype.

T Takahashi1, M Aoki, M Tateyama, E Kondo, T Mizuno, Y Onodera, R Takano, H Kawai, K Kamakura, H Mochizuki, M Shizuka-Ikeda, M Nakagawa, Y Yoshida, J Akanuma, K Hoshino, H Saito, M Nishizawa, S Kato, K Saito, T Miyachi, H Yamashita, M Kawai, T Matsumura, S Kuzuhara, T Ibi, K Sahashi, H Nakai, T Kohnosu, I Nonaka, K Arahata, R H Brown, H Saito, Y Itoyama.   

Abstract

OBJECTIVE: To study dysferlin gene mutations and genotype-phenotype correlations in Japanese patients with Miyoshi myopathy (MM).
BACKGROUND: MM is an autosomal recessive distal muscular dystrophy that arises from mutations in the dysferlin gene. This gene is also mutated in families with limb girdle muscular dystrophy 2B.
METHODS: The authors examined 25 Japanese patients with MM. Genomic DNA was extracted from the peripheral lymphocytes of the patients. The PCR products of each of 55 exons were screened by single strand conformation polymorphism or direct sequencing from the PCR fragments.
RESULTS: The authors identified 16 different mutations in 20 patients with MM; 10 were novel. Mutations in Japanese patients are distributed along the entire length of the gene.
CONCLUSIONS: Four mutations (C1939G, G3370T, 3746delG, and 4870delT) are relatively more prevalent in this population, accounting for 60% of the mutations in this study. This study revealed that the G3370T mutation was associated with milder forms of MM and the G3510A mutation was associated with a more severe form.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796534     DOI: 10.1212/01.wnl.0000068333.43005.12

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.

Authors:  Alberto Lerario; Filippo Cogiamanian; Chiara Marchesi; Marzia Belicchi; Nereo Bresolin; Laura Porretti; Yvan Torrente
Journal:  BMC Musculoskelet Disord       Date:  2010-07-11       Impact factor: 2.362

2.  Identification of a Novel Mutation in the Titin Gene in a Chinese Family with Limb-Girdle Muscular Dystrophy 2J.

Authors:  Wen Zheng; Han Chen; Xiong Deng; Lamei Yuan; Yan Yang; Zhi Song; Zhijian Yang; Yuan Wu; Hao Deng
Journal:  Mol Neurobiol       Date:  2015-09-21       Impact factor: 5.590

3.  Nonsyndromic Early-Onset Cone-Rod Dystrophy and Limb-Girdle Muscular Dystrophy in a Consanguineous Israeli Family are Caused by Two Independent yet Linked Mutations in ALMS1 and DYSF.

Authors:  Csilla H Lazar; Adva Kimchi; Prasanthi Namburi; Mousumi Mutsuddi; Lina Zelinger; Avigail Beryozkin; Shiran Ben-Simhon; Alexey Obolensky; Ziva Ben-Neriah; Zohar Argov; Eli Pikarsky; Yakov Fellig; Devorah Marks-Ohana; Rinki Ratnapriya; Eyal Banin; Dror Sharon; Anand Swaroop
Journal:  Hum Mutat       Date:  2015-07-14       Impact factor: 4.878

4.  Clinical and genetic analysis of Korean patients with Miyoshi myopathy: identification of three novel mutations in the DYSF gene.

Authors:  Hyun-Jung Cho; Duck Hyun Sung; Eun-Jin Kim; Chul Ho Yoon; Chang-Seok Ki; Jong-Won Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

5.  Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia.

Authors:  Norah Alharbi; Rawan Matar; Edward Cupler; Hindi Al-Hindi; Hatem Murad; Iftteah Alhomud; Dorota Monies; Ali Alshehri; Mossaed Alyahya; Brian Meyer; Saeed Bohlega
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

6.  Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer.

Authors:  William E Grose; K Reed Clark; Danielle Griffin; Vinod Malik; Kimberly M Shontz; Chrystal L Montgomery; Sarah Lewis; Robert H Brown; Paul M L Janssen; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

7.  Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.

Authors:  Mafalda Cacciottolo; Gelsomina Numitone; Stefania Aurino; Imma Rosaria Caserta; Marina Fanin; Luisa Politano; Carlo Minetti; Enzo Ricci; Giulio Piluso; Corrado Angelini; Vincenzo Nigro
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

8.  Heterogeneous characteristics of Korean patients with dysferlinopathy.

Authors:  Hyung Jun Park; Ji-Man Hong; Gyoung Im Suh; Ha Young Shin; Seung Min Kim; Il Nam Sunwoo; Bum Chun Suh; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153

9.  Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.

Authors:  Toshiaki Takahashi; Masashi Aoki; Naoki Suzuki; Maki Tateyama; Chikako Yaginuma; Hitomi Sato; Miho Hayasaka; Hitomi Sugawara; Mariko Ito; Emi Abe-Kondo; Naoko Shimakura; Tohru Ibi; Satoshi Kuru; Tadashi Wakayama; Gen Sobue; Naoki Fujii; Toshio Saito; Tsuyoshi Matsumura; Itaru Funakawa; Eiichiro Mukai; Toru Kawanami; Mitsuya Morita; Mineo Yamazaki; Takashi Hasegawa; Jun Shimizu; Shoji Tsuji; Shigeki Kuzuhara; Hiroyasu Tanaka; Masaru Yoshioka; Hidehiko Konno; Hiroshi Onodera; Yasuto Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-15       Impact factor: 10.154

10.  Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.

Authors:  Jens A Petersen; Thierry Kuntzer; Dirk Fischer; Maja von der Hagen; Angela Huebner; Veronika Kana; Johannes A Lobrinus; Wolfram Kress; Elisabeth J Rushing; Michael Sinnreich; Hans H Jung
Journal:  BMC Neurol       Date:  2015-10-06       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.